Summary
Latest filing:
Vincent Michael Lawton is Director of Addex Therapeutics Ltd. (ADXN). 1 SEC Form 4 filing on record, dated 4 September 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Vincent Michael Lawton has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Vincent Michael Lawton's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Matthew Gline - $46.22M of ROIV open-market activity in the last 12 months
- Larry Robbins - $46.04M of BFLY open-market activity in the last 12 months
- Michael John Kazley - $45.65M of SDEV open-market activity in the last 12 months
- R01 Fund LP - $45.65M of SDEV open-market activity in the last 12 months
- Brian Taylor Slingsby - $43.35M of MLYS open-market activity in the last 12 months
- Framework Ventures IV L.P. - $42.62M of SDEV open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Vincent Michael Lawton?
Vincent Michael Lawton is a corporate insider, tracked as Director of Addex Therapeutics Ltd. (ADXN). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Vincent Michael Lawton submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Vincent Michael Lawton's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Vincent Michael Lawton and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
